Literature DB >> 3815313

Agreement rates and American-Japanese pathologists' comparability of a modified Working Formulation for non-Hodgkin's lymphomas. An analysis of the cases collected for the Fifth International Workshop on Chromosomes in Leukemia-Lymphoma.

K Nanba, H Yamamoto, N Kamada, M Kikuchi, T Suchi, G Frizzera, C W Berard, K Shimamura, Y Kaneko, M Sakurai.   

Abstract

Histopathologic slides of 368 cases collected from 16 institutions around the world for the Fifth International Chromosome Workshop were independently reviewed by a group of five hematopathologists consisting of two Americans and three Japanese. Agreement rates of their diagnoses using the Working Formulation (WF) for non-Hodgkin's lymphomas were studied. A modified classification scheme of the WF was used in order to define cytologic subtypes more specifically, enabling 65 possible diagnostic choices. Data analyses by computer revealed that at least four out of five diagnostic agreements were observed in 290 cases (78.9%). Similar agreements were observed in more than 80% of the cases for most of the categories of the WF, excepting diffuse small cleaved (73.3%), diffuse mixed (64.2%), diffuse large cell (76.5%), and immunoblastic lymphoma (70.2%). Agreement rates between American and Japanese pathologists did not demonstrate statistically significant differences against expected values. It was concluded that the WF was a reliable and useful classification system for multi-institutional as well as international projects, although refinements may be necessary in some categories for better diagnostic agreement.

Entities:  

Mesh:

Year:  1987        PMID: 3815313     DOI: 10.1002/1097-0142(19870415)59:8<1463::aid-cncr2820590812>3.0.co;2-f

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  The incidence of non-Hodgkin's lymphoma and its histologic subtypes in Asian migrants to the United States and their descendants.

Authors:  L J Herrinton; M Goldoft; S M Schwartz; N S Weiss
Journal:  Cancer Causes Control       Date:  1996-03       Impact factor: 2.506

2.  A phase II study of VEPA/FEPP chemotherapy for aggressive lymphoma in elderly patients: Japan Clinical Oncology Group Study JCOG9203.

Authors:  Fumi Mizoroki; Yuko Hirose; Masayuki Sano; Haruhiko Fukuda; Kensei Tobinai; Masanobu Nakata; Masafumi Taniwaki; Fumio Kawano; Kimiharu Uozumi; Kenichi Sawada; Shiro Fukuhara; Kaori Nasu; Yoichiro Ohno; Hironobu Toki; Atsushi Togawa; Masahiro Kikuchi; Tomomitsu Hotta; Masanori Shimoyama
Journal:  Int J Hematol       Date:  2006-01       Impact factor: 2.490

3.  Primary orbital malignant lymphoma: a clinicopathology study of 17 cases.

Authors:  H Nikaido; H K Mishima; Y Kiuchi; K Nanba
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.